Skip to main content

Cytokine Release in the Context of T Cell Bispecific Antibody (TCB) Therapies - Gabrielle Leclerq, Ph.D.

Published Date

Cytokine release in the context of T cell bispecific antibody (TCB) therapies: biological mechanisms and mitigation strategies Presented by Gabrielle Leclerq, Ph.D. - Doctorate Scientist, Roche Pharma Research and Early Development, Roche Innovation Center Zürich, Switzerland Presented on 17 June 2022 in Heidelberg, Germany